News
2023.12.06
Continuing from last year, Dx&Vx has once again been awarded as the top exporter this year, accelerating its growth in the international sector. On the 6th, Dx&Vx announced that it was awarded the 'Top in $7 Million Exports' at the recent Trade Day event held at COEX. Following last year's achievement as the 'Top in $3 Million Exports,' the company has achieved more than double the export performance. "Despite the domestic and international low birthrate trend, the continuous success is attributed to the development of innovative microbiome infant products." Dx&Vx is a microbiome-based self-developed product that is diversifying its export market in addition to the existing Chinese market, so it expects steady growth in the overseas export sector. Recently, it signed an export contract for healthcare products including "Formulamate OFMOM" in the European Union (EU) region, and is currently discussing exports to a number of countries, including Southeast Asia. Dx&Vx is in the process of establishing its own brand malls for Dx&Vx and Ofmom on major online platforms in key global countries. The company plans to open its own brand malls on global online shopping platforms, including Amazon in the United States, Rakuten and Amazon Japan in Japan, Tmall (Alibaba) and TikTok (Douyin) in China, and Shopee and Lazada in Southeast Asia. Through both direct overseas sales and parallel importation methods, Dx&Vx aims to sell a total of 12 products, including the Nutrition brand Ofmom series and products developed by CoreeItaly, to global consumers. "We have achieved the achievement of exporting $7 million through active research and development and strategic overseas marketing to strengthen the competitiveness of microbiome infants and toddlers despite the adverse conditions of a global decline in fertility rates," a Dx&Vx official said. "As the global competitiveness of our brand products has been proven, we expect export growth in the global market beyond China to accelerate further." Source: Edaily